First-in-Human Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

First-in-Human Trials in Colombia

First-in-Human Trials in Colombia – Clinical Trials Services

Colombia has recently emerged as a prominent player in the realm of medical research and innovation, particularly in the area of first-in-human trials. These trials mark a crucial milestone in testing novel medical interventions on human subjects for the first time.

In this blog, we will explore the growing significance of first-in-human trials in Colombia, the factors driving this trend, the benefits and challenges associated with such trials, and their potential impact on healthcare advancements in the country.

The Rise of First-in-Human Trials in Colombia

Colombia has made significant progress in establishing itself as a preferred destination for first-in-human trials. This progress can be attributed to various factors. First, the country possesses a well-developed healthcare infrastructure, including leading research institutions and highly skilled medical professionals.

Second, Colombia’s diverse population provides researchers with a valuable demographic and genetic diversity for their trials. Lastly, the Colombian government has implemented favorable regulations and incentives, encouraging both local and international pharmaceutical companies to choose Colombia as a destination for their first-in-human trials.

Advantages of First-in-Human Trials

First-in-human trials offer numerous benefits that contribute to medical advancements. These trials enable researchers to evaluate the safety, dosage, and potential efficacy of innovative interventions in human subjects, marking a significant step towards transforming scientific discoveries into real-world treatments.

By hosting such trials, Colombia provides patients with early access to groundbreaking therapies that may not be available elsewhere. Additionally, first-in-human trials foster collaboration between national and international researchers, facilitating knowledge exchange and enhancing Colombia’s global standing in the field of medical research.

Challenges and Ethical Considerations

While first-in-human trials hold great potential, they also present unique challenges and ethical considerations. Ensuring participant safety is paramount, and strict protocols must be followed to minimize risks. Obtaining informed consent and maintaining transparency throughout the trial process are critical ethical considerations. Moreover, effective monitoring and regulation are necessary to prevent any potential exploitation.

Colombia has taken significant steps to address these challenges by aligning its regulations with international standards and working closely with ethical review boards to safeguard participant rights.

First-in-Human Trials in Colombia

First-in-Human Trials in Colombia

First-in-Human Trials in Colombia

Driving Healthcare Advancements

The active involvement of Colombia in first-in-human trials has positioned the country as a key driver of healthcare advancements. Collaboration with pharmaceutical companies and research institutions has facilitated the introduction of cutting-edge research projects and clinical trials.

This fosters innovation, attracts investment, and spurs growth in the local healthcare industry. Furthermore, knowledge gained from these trials can inform healthcare policies, support the development of personalized medicine, and enhance treatment outcomes for patients across the country.

Current Initiatives and Success Stories

Colombia has already witnessed notable success stories in the realm of first-in-human trials. These trials have focused on various areas, including innovative cancer treatments, advanced medical devices, and groundbreaking gene therapies.

The positive outcomes and significant contributions to medical science have not only provided patients with access to life-changing treatments but have also attracted further attention from global pharmaceutical companies and researchers. This success has solidified Colombia’s position as a desirable destination for first-in-human trials and has opened doors for exciting collaborations and future breakthroughs.

Collaborations and Knowledge Exchange

Colombia actively encourages collaborations between local and international researchers, which promotes knowledge exchange and fosters innovation. These collaborations facilitate the sharing of expertise, resources, and technologies, leading to accelerated advancements in medical research.

Additionally, international collaborations enable Colombian researchers to gain exposure to diverse perspectives and approaches, enhancing their skills and expanding their professional networks. Such interactions contribute to the overall growth and reputation of Colombia’s healthcare and research sectors, positioning the country as an influential player in the global medical research landscape.


Colombia’s growing involvement in first-in-human trials signifies its commitment to advancing medical research and innovation. With a strong healthcare infrastructure, a diverse population, and favorable regulatory frameworks, Colombia has positioned itself as an attractive destination for conducting these pivotal trials.

By embracing the opportunity presented by first-in-human trials, Colombia has the potential to drive healthcare advancements, enhance patient access to cutting-edge treatments, and contribute significantly to the global pursuit of improved healthcare outcomes. The future of medical research in Colombia looks promising, with first-in-human trials at the forefront of transformative medical breakthroughs.

First-in-Human Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

First-in-Human Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
First-in-Human Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

First-in-Human Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

First-in-Human Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

First-in-Human Trials in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

First-in-Human Trials in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
First-in-Human Trials in Colombia

The Cohortias Team

First-in-Human Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

First-in-Human Trials in Colombia

Network & Partnerships